Stella Sarma focuses her practice on EU, UK and Greek competition law, advising clients on merger control and global cartel investigations. She has unparalleled experience steering worldwide merger control proceedings in complex cross-border transactions before the European Commission and UK CMA, particularly in the technology and healthcare industries. She regularly guides multijurisdictional antitrust investigations at the EC, UK and national levels, especially in the automotive and tech sectors.
Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).
Cooley advised Tenable, an exposure management company, on its definitive agreement to acquire Apex Security, an innovator in securing the rapidly expanding artificial intelligence attack surface.
Cooley advised Datadog (Nasdaq: DDOG), a monitoring and security platform for cloud applications, on its acquisition of Eppo, a feature flagging and experimentation platform that will tightly integrate with Datadog’s existing product analytics suite.
Cooley advised Feedzai, a global leader in fraud and financial crime prevention, on its acquisition of Demyst, including Demyst’s Zonic data workflow orchestration platform, intellectual property and sophisticated data-integration capabilities.
Cooley advised Logik.ai, an industry leader offering a modern, artificial intelligence (AI)-powered, composable configure, price and quote solution, on its acquisition by ServiceNow (NYSE: NOW), the AI platform for business transformation.
